Cartilage Repair Global Market Report 2024

The cartilage repair market size has grown rapidly in recent years. It will grow from $1.24 billion in 2023 to $1.42 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The growth observed in the historical period can be attributed to factors such as the increasing incidence of joint disorders, growing awareness and diagnosis rates, rising healthcare expenditure, as well as collaborations and partnerships within the healthcare industry.

The cartilage repair market size is expected to see rapid growth in the next few years. It will grow to $2.3 billion in 2028 at a compound annual growth rate (CAGR) of 12.8%. The anticipated growth in the forecast period can be attributed to factors such as the growing aging population, an increase in sports injuries, regulatory support for advanced therapies, and the rising preference among patients for non-invasive treatments. Major trends expected in the forecast period include technological advancements in cartilage repair, regulatory approvals and standardization of procedures, a growing preference among patients for biologics in treatments, and the development of healthcare infrastructure to support these advanced therapies.

The anticipated increase in road accidents and sports-related injuries is set to drive the growth of the cartilage repair market in the future. Road accidents encompass incidents involving vehicles, pedestrians, or cyclists on public roads, while sports-related injuries refer to harm sustained during various sports and physical activities. The surge in both types of injuries significantly boosts the demand for cartilage repair procedures, aiming to restore damaged cartilage, alleviate pain, and enhance joint function resulting from such injuries. For example, a report by the Insurance Institute for Highway Safety in May 2023 highlighted an increase in road crashes in the United States from 35,935 in 2020 to 39,508 in 2021, with a corresponding rise in fatalities from 39,007 in 2020 to 42,939 in 2021. Additionally, Cary Orthopaedica reported in August 2021 that over 3.5 million children and teenagers in the United States suffer from sports-related injuries annually. Hence, the upsurge in road accidents and sports-related injuries is a driving force behind the growth of the cartilage repair market.

The increasing incidences of diabetes and obesity are poised to propel the cartilage repair market's growth in the future. Diabetes, characterized by elevated blood glucose levels, and obesity, defined by a body mass index of 30 or more, can hinder cartilage repair by affecting inflammatory responses and compromising the regenerative capacity of cartilage tissues. The International Diabetes Federation reported in June 2022 that diabetes prevalence has risen to 10.5% globally, with an estimated 783 million adults expected to have diabetes by 2045. Additionally, the World Health Organization noted in March 2022 that 650 million adults, 340 million teenagers, and 39 million children are projected to be obese, with 167 million expected to be overweight or obese by 2025. Therefore, the increasing occurrences of diabetes and obesity are contributing to the growth of the cartilage repair market.

The high cost associated with cartilage repair surgeries serves as a potential restraint in the cartilage repair market. These surgeries, often addressing joint-related issues such as those in the knee, hip, or shoulder, come with substantial treatment costs, limiting accessibility for individuals with joint problems. This limitation is particularly challenging for patients lacking sufficient health insurance coverage or financial means. For example, Becker's Healthcare reported in June 2023 that the average cost for a knee arthroscopy with cartilage removal at an ambulatory surgery center (ASC) was $3,412, while the same procedure at a hospital outpatient department (HOPD) averaged $5,226. Consequently, the high costs associated with cartilage repair surgeries are impeding the growth of the cartilage repair market.

Prominent companies in the cartilage repair market are focused on developing innovative products such as Chondro-Gide, aimed at protecting injured cartilage, promoting healing, and obtaining approvals for cartilage treatments. Chondro-Gide, or articular cartilage cover, is a bilayer collagen membrane utilized in a one-step cartilage repair technique. Geistlich Pharma AG received breakthrough device designation (BDD) for Chondro-Gide from the U.S. Food and Drug Administration in February 2021. Chondro-Gide is known for its high-purity collagen membrane, leveraging the body's healing potential to treat cartilage defects in the knee using the Autologous Matrix-Induced Chondrogenesis (AMIC) technique.

In July 2022, Bioventus Inc. acquired CartiHeal Ltd. for $315 million, enhancing its cartilage repair market position with access to CartiHeal's product Agili-C and leveraging its expertise in cartilage repair. CartiHeal Ltd. is a medical device company based in the United States, specializing in the development of cartilage products for various treatments.

Major companies operating in the cartilage repair market report are Johnson and Johnson Services Inc., Medtronic PLC, Stryker Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith And Nephew PLC, Arthrex Inc., CONMED Corporation Inc., Meril Life Sciences Pvt. Ltd., Medacta International SA, RTI Surgical Inc., Japan MDM Inc., Vericel Corporation, Anika Therapeutics Inc., Mathys AG Bettlach, JRI Orthopaedics Ltd., Auxein Medical ltd., MEDIPOST Co Ltd., DePuy Synthes Companies, Arthro Kinetics AG, Waldemar Link GmbH and Co.KG, Osiris Therapeutics Inc., Teijin Nakashima Medical Co Ltd., Collagen Solutions LLP, BioTissue SA, ISTO Technologies Inc., Regentis Biomaterials Ltd., Histogenics Corporation, Evolutis India Pvt. Ltd.

North America was the largest region in the cartilage repair market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cartilage repair market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cartilage repair market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cartilage repair is a medical process aimed at treating and restoring damaged or injured cartilage tissue in the body. Cartilage, a connective tissue covering the ends of bones in joints, serves as a cushion and lubricant, facilitating smooth and pain-free movement. Procedures for cartilage repair are designed to address issues related to damaged or injured cartilage and promote the healing and regeneration of this tissue.

The main types of treatments for cartilage repair can be categorized as cell-based and non-cell-based. Cell-based treatments involve medical therapies that utilize living cells. These treatments are applicable at various sites, including the knee, hip, ankle, foot, and others. The applications encompass a variety of cartilage types, such as hyaline cartilage and fibrocartilage. Cartilage repair procedures are conducted by various end-users, including hospitals and clinics, as well as ambulatory surgical centers (ASCs), among others.

The cartilage repair market research report is one of a series of new reports that provides cartilage repair market statistics, including cartilage repair industry global market size, regional shares, competitors with a cartilage repair market share, detailed cartilage repair market segments, market trends and opportunities, and any further data you may need to thrive in the cartilage repair industry. This cartilage repair market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cartilage repair market consists of revenues earned by entities by providing services such as arthroscopy, allograft transplantation, biologic treatments, stem cell therapies, and microfracture. The market value includes the value of related goods sold by the service provider or included within the service offering. The cartilage repair market also includes sales of synthetic scaffolds, cartilage transplants, orthopedic implants, and diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.